Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

No established treatment effectively stops inflammation and prevents hair loss in folliculitis decalvans.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

N-acetylcysteine may help treat trichotillomania.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Cannabidiol shows promise as an effective treatment for acne.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

More personalized and effective treatments for androgenetic alopecia are needed.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.